Is prednisone effective for treating urticaria?

Prednisone for Urticaria: Limited Benefit in Most Cases

Prednisone should NOT be routinely used for urticaria, as the most recent high-quality evidence shows it provides no additional benefit over antihistamines alone for acute urticaria and should be avoided in chronic urticaria except in very specific circumstances.

Treatment Algorithm Based on Urticaria Type

For Acute Urticaria

Start with second-generation H1-antihistamines alone (e.g., cetirizine, levocetirizine, fexofenadine) 1. The evidence against adding prednisone is compelling:

• A 2024 meta-analysis found that among patients with a high baseline response rate to antihistamines (95.8%), adding corticosteroids improved urticaria by only 2.2% absolute difference (NNT=45), while increasing adverse events by 15% (NNH=9) 2

• A 2018 double-blind RCT showed 76% of patients on levocetirizine alone achieved complete itch resolution at 2 days versus only 62% with added prednisone 3

• A 2021 RCT found no significant difference in pruritus scores at 60 minutes between antihistamine alone versus antihistamine plus dexamethasone, and oral corticosteroids were associated with MORE persistent urticaria activity at follow-up 4

Exception: Short-course prednisone (50 mg daily for 3 days in adults, though lower doses often work) may be considered ONLY for severe acute urticaria when symptoms are intolerable 5. However, even this recommendation comes from older 2007 guidelines, and newer evidence suggests limited benefit 2, 6.

For Chronic Spontaneous Urticaria (CSU)

The 2022 international guidelines provide a clear 3-step algorithm 1:

1. First-line: Standard-dose second-generation H1-antihistamine
2. If inadequate control after 2-4 weeks: Increase antihistamine up to 4-fold
3. Second-line: Omalizumab 300 mg every 4 weeks (can updose to 600 mg every 14 days if needed)
4. Third-line: Cyclosporine (only after omalizumab failure)

Long-term oral corticosteroids should NOT be used in chronic urticaria (Strength of recommendation A) 5 except in very selected cases under regular specialist supervision.

For Specific Urticaria Subtypes

Short tapering courses of oral steroids over 3-4 weeks may be necessary for:

• Urticarial vasculitis 5
• Severe delayed pressure urticaria 5

These are the ONLY chronic urticaria scenarios where corticosteroids have documented benefit.

Key Clinical Pitfalls to Avoid

1. Don't prescribe prednisone reflexively for acute urticaria - The evidence shows antihistamines alone are equally effective in most cases, with fewer adverse effects 2, 4, 3

2. Don't use long-term corticosteroids for chronic urticaria - This leads to significant adverse effects without addressing the underlying mast cell activation 1, 5

3. Don't skip antihistamine updosing - Before considering any other therapy, increase the antihistamine dose up to 4-fold 1

4. Recognize when corticosteroids cause harm - The 2021 RCT showed oral prednisolone was associated with MORE persistent urticaria activity at 1-week and 1-month follow-up 4

Evidence Quality Considerations

The evidence against routine prednisone use has strengthened considerably:

• Older evidence (1995) suggested benefit from prednisone bursts 7, but this study had significant methodological limitations
• Recent high-quality RCTs (2018,2021) consistently show no benefit 4, 3
• The 2024 meta-analysis confirms that benefit is minimal even in the best-case scenario, while adverse events increase by 15% 2

The 2022 international guidelines notably removed corticosteroids from the standard treatment algorithm for chronic urticaria, streamlining from 4 steps to 3 steps (antihistamines → omalizumab → cyclosporine) 1.

Adverse Effects Profile

When prednisone is used, expect adverse events in approximately 15% more patients compared to antihistamines alone 2. The FDA label documents extensive potential adverse effects including hyperglycemia, hypertension, immunosuppression, psychiatric disturbances, and HPA axis suppression 8.

Bottom line: Reserve prednisone for the rare severe acute urticaria case with intolerable symptoms, or for specific chronic subtypes (urticarial vasculitis, severe delayed pressure urticaria). For the vast majority of urticaria patients, antihistamines alone—with appropriate updosing—are the evidence-based choice.